Report ID: SQMIG35A2623
Report ID:
SQMIG35A2623 |
Region:
Global |
Published Date: September, 2024
Pages:
165
|
Tables:
65 |
Figures:
75
North America led global infection control market by leveraging over 30% in revenue. Through the various strategic partnerships, the major players in the industry have forged to expand their product lines and expand their infection control capabilities, it has achieved this significant market share. Furthermore, the resulting leading portion taken by North America is mainly due to the increased attempts of the established corporations throughout this area for expansion. For instance, Advanced Sterilization Products introduced the STERRAD 100NX System with ALLClear to the US and is now looking to further penetrate into Europe, Africa, and the Middle East.
Asia Pacific is expected to grow at the highest CAGR of 8.3% through the projection period due to unprecedented changes in the region's healthcare standards and infrastructure, increasing expenditure on healthcare, and the growth in the number of companies outsourcing. Since infection control is the biggest factor in the development of the Asia Pacific region, government organizations are focusing more on achieving high on this aspect. The escalating practice of outsourcing by established market participants in mature economies to Asian Pacific region companies makes it the largest impetus for market expansion.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2623